Request Deal Involvement

Omnicell completed the acquisition of 340B Link from Pharmaceutical Strategies Group for $225m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Greenhill & Co

financial advisors

Greenhill & Co

Sidley Austin

legal advisors

Sidley Austin

Joele Frank

pr advisors

Joele Frank

Alston & Bird

legal advisors to financial advisors

Alston & Bird

Norton Rose Fulbright

legal advisors

Norton Rose Fulbright

Houlihan Lokey

financial advisors

Houlihan Lokey

Sloane & Company

pr advisors

Sloane & Company

or

Principals

340B LINK

target

340B LINK

OMNICELL INC

bidder

OMNICELL INC

PHARMACEUTICAL STRATEGIES GROUP

vendor

PHARMACEUTICAL STRATEGIES GROUP

BLUE WOLF CAPITAL

vendor

BLUE WOLF CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Omnicell completed the acquisition of 340B Link from Pharmaceutical Strategies Group for $225m.